However, MALAT1 can bind to EZH2 and then induces cancer malignant development in aggressive renal cell carcinoma cells [52], esophageal squamous cell carcinoma cells [53] and gastric cancer cells [54] in vitro and in tumor tissue samples. Here, EZH2 is linked to neoplasm.